These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 18667841)

  • 41. Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis.
    Kobayashi S; Kishimoto T; Kamata S; Otsuka M; Miyazaki M; Ishikura H
    Cancer Sci; 2007 May; 98(5):726-33. PubMed ID: 17425689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
    Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
    Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C.
    Wang J; Zhang B; Guo Y; Li G; Xie Q; Zhu B; Gao J; Chen Z
    Pharmacology; 2008; 82(2):148-55. PubMed ID: 18667841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.